Copyright
©The Author(s) 2015.
World J Gastrointest Pathophysiol. Nov 15, 2015; 6(4): 193-202
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.193
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.193
Drug target | Potential treatment alternatives |
NGF | Tanezumab |
TRPV1 | TRPV1 antagonist |
PAR2 | Trypsin inhibitors |
Mast cell | Ketotifen |
Interleukin 1 | Recombinant interleukin-1 receptor antagonist |
Interleukin 6 | Interleukin-6 antagonist |
Central sensitization | Ketamine, dextromethrophan, pregabalin, tricyclic antidepressants, and noradrenaline reuptake inhibitors |
- Citation: Atsawarungruangkit A, Pongprasobchai S. Current understanding of the neuropathophysiology of pain in chronic pancreatitis. World J Gastrointest Pathophysiol 2015; 6(4): 193-202
- URL: https://www.wjgnet.com/2150-5330/full/v6/i4/193.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v6.i4.193